secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2025-04-21T23:59:59+00:00
Accession:  0001104659-25-036851
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 5.08, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm Cell Therapeutics amends bylaws to reduce quorum to 1/3; sets 2025 annual meeting for June 25
--------------------------------------------------------------------------------

- Board approved reducing stockholder quorum from majority to one-third of outstanding shares.
- 2025 Annual Meeting to be held virtually on June 25, 2025 at 10:00 a.m. ET.
- Record date for voting is May 7, 2025; shareholder proposals due by same date.
- Director nominations under universal proxy rules must be received by May 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465925036851/0001104659-25-036851-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465925036851/tm2512729d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-036851

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer